Vivimed Labs Limited has informed the Exchange about Corporate Insolvency Resolution Process

Nclt Insolvency AdmittedRegulatory & Legal View source PDF

VIVIMEDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-2.3%1-day move

₹6.89

prior close

₹6.90

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.0-0.1-0.1-2.3+0.0-0.6+2.3+0.1-3.2-3.5-7.1-14.4-26.0

Up moveDown movePending

AI summary

The National Company Law Tribunal (NCLT), Bengaluru Bench has admitted Vivimed Labs Limited into the Corporate Insolvency Resolution Process under the Insolvency and Bankruptcy Code, 2016. The insolvency commencement date is 15.04.2026. The company has appointed T Narayana Swamy as the Interim Resolution Professional. Creditors have been called upon to submit their claims with proof by 01.05.2026. The estimated closure date for the resolution process is 11.10.2026. The company was originally incorporated on 22.09.1988 and is registered in Karnataka.

Likely market impact

This is an extremely negative development for shareholders as the company is now under formal insolvency proceedings. Existing equity shareholders will likely face severe dilution or complete loss of value if a resolution plan results in debt-for-equity swap or if the company is liquidated. Trading in the stock may be suspended or face significant price collapse.